The research is consistent
And another study from George Washington University found that people on GLP-1 medications had a higher risk of experiencing hair loss
To further investigate this, an in vitro senescence model was established using TM3 mouse Leydig cells treated with H2O2
Retatrutidesometimes called Reta, or informally GLP-3is the next evolution in a class of weight loss drugs known as GLP-1 receptor agonists
Many patients choose B12 injections as a proactive wellness treatment
They compared 12,004 records of patients on a GLP-1 receptor agonist, like semaglutide or tirzepatide, to 15,221 using SGLT-2 drugs and 11,964 GLP-1 drug patients to 11,238 people taking DPP-4 inhibitors